631P Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration resistant prostate cancer in an open-label phase Ib study

Autor: Rodriguez-Vida, A., Maroto Rey, J.P., Font Pous, A., Martin, C., Mellado, B., Corbera Lloret, A., Orrillo Sarmiento, M., Reig Torras, O., Querol Ninerola, R., Cano, L., Palazon, A., Alonso, J., Galtes, S., Juanpere, N., Juan, O., Bellmunt, J.
Zdroj: In Annals of Oncology September 2021 32 Supplement 5:S665-S665
Databáze: ScienceDirect